Suche

Arzneimittelinteraktionen Praxisleitfaden für das Fachpersonal

Arzneimittelinteraktionen beschreiben die pharmakokinetische oder pharmakodynamische Beeinflussung eines Wirkstoffes durch einen anderen, was zu veränderten Plasmakonzentrationen oder modifizierten Zielwirkungen führen kann. …

Aubagio · 4.5 · 8 There was an increase in mean rosuvastatin Cmax and AUC (2.65- and 2.51-fold, respectively), following repea

Brilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol

Brilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol

Brilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol

Clopidogrel Krka d.d. (previously Zopya) · 4.5 · Rosuvastatin: Clopidogrel has been shown to increase rosuvastatin exposure in patients by 2-fold (AUC) and 1.3

Clopidogrel Krka · 4.5 · Rosuvastatin: Clopidogrel has been shown to increase rosuvastatin exposure in patients by 2-fold (AUC) and 1.3

Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol

pubmed · 30483816

Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin

pubmed · 42396714